Get started
Author

Roberto Rodríguez‐Ibeas

Observed names: R. Rodriguez-Ibeas, R. Rodriguez-ibeas, R. Rodríguez Ibeas, R. Rodríguez-Ibeas, Roberto Rodriguez-Ibeas, Roberto Rodríguez, Roberto Rodríguez Ibeas, Roberto Rodríguez-Ibeas, Roberto Rodríguez-ibeas, Roberto Rodríguez–Ibeas
Observed institution: Universidad de La Rioja
ORCID: 0000-0001-6604-7993
Observed ORCID: 0000-0001-6604-7993
OpenAlex ID: A5005870729
Environmental Product Differentiation and Environmental Awareness
2006 · Roberto Rodríguez-Ibeas · Environmental and Resource Economics · 89
The Use of Risk-Sharing Contracts in Healthcare: Theoretical and Empirical Assessments
2019 · Fernando Antonanzas, Carmelo Juárez-Castelló, et al. · PharmacoEconomics · 61
Transferability indices for health economic evaluations: methods and applications
2008 · Fernando Antonanzas, Roberto Rodríguez‐Ibeas, et al. · Health Economics · 52
Should health authorities offer risk-sharing contracts to pharmaceutical firms? A theoretical approach
2011 · Fernando Antonanzas, Carmelo Juarez-Castello, et al. · Health Economics Policy and Law · 49
Some economics on personalized and predictive medicine
2014 · F. Antoñanzas, C. A. Juárez-Castelló, et al. · The European Journal of Health Economics · 23
Methodological reviews of economic evaluations in health care: what do they target?
2013 · Maria-Florencia Hutter, Roberto Rodríguez-Ibeas, et al. · The European Journal of Health Economics · 22
Using point-of-care diagnostic testing for improved antibiotic prescription: an economic model
2021 · F. Antoñanzas, C. A. Juárez-Castelló, et al. · Health Economics Review · 20
PDF
Genetic testing in the European Union: does economic evaluation matter?
2011 · Fernando Antoñanzas, R. Rodríguez-Ibeas, et al. · The European Journal of Health Economics · 20
Personalized Medicine and Pay for Performance: Should Pharmaceutical Firms be Fully Penalized when Treatment Fails?
2018 · Fernando Antoñanzas, Roberto Rodríguez-Ibeas, et al. · PharmacoEconomics · 18
Los medicamentos en la Unión Europea: el tándem comercio-salud
2005 · Fernando Antoñanzas, Roberto Rodríguez, et al. · Gaceta Sanitaria · 15
PDF
Implementation of risk-sharing contracts as perceived by Spanish hospital pharmacists
2019 · Reyes Lorente, Fernando Antonanzas, et al. · Health Economics Review · 14
PDF
Impacto del Real Decreto-Ley 16/2012 sobre el copago farmacéutico en el número de recetas y en el gasto farmacéutico
2014 · Fernando Antoñanzas Villar, Roberto Rodríguez-Ibeas, et al. · Revista Española de Salud Pública · 13
PDF
Feeding the economics of obesity in the EU in a healthy way
2010 · Fernando Antonanzas, Roberto Rodríguez · The European Journal of Health Economics · 12
PDF
Diagnostic Testing for Sepsis: A Systematic Review of Economic Evaluations
2021 · Paula Rojas-Garcia, Simon van der Pol, et al. · Antibiotics · 11
PDF
Efficiency of Diagnostic Testing for Helicobacter pylori Infections—A Systematic Review
2021 · Paula Rojas García, Simon van der Pol, et al. · Antibiotics · 11
PDF
EMA Priority Medicines scheme (PRIME): will more paying-for-performance agreements be needed due to immature data?
2017 · F. Antoñanzas, C. A. Juárez-Castelló, et al. · The European Journal of Health Economics · 10
PDF
Alcohol consumption in the EU: health economics and policy issues under a permanent debate
2008 · Fernando Antoñanzas, Roberto Rodríguez-Ibeas, et al. · The European Journal of Health Economics · 8
Should the patent system for pharmaceuticals be replaced? A theoretical approach
2014 · Fernando Antoñanzas, Roberto Rodríguez-Ibeas, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 7
Healthy vs. unhealthy food: a strategic choice for firms and consumers
2011 · Fernando Antoñanzas, Roberto Rodríguez-Ibeas · Health Economics Review · 7
PDF
Regulatory Enforcement with Discretionary Fining and Litigation
2002 · Roberto Rodríguez–Ibeas · Bulletin of Economic Research · 7
Pre-approval incentives to promote adoption of personalized medicine: a theoretical approach
2019 · F. Antoñanzas, C. A. Juárez-Castelló, et al. · Health Economics Review · 6
PDF
Improving health care systems by building ‘more Europe’
2016 · F. Antoñanzas, C. A. Juárez-Castelló, et al. · The European Journal of Health Economics · 6
PDF
Innovation, loyalty and generic competition in pharmaceutical markets
2010 · Fernando Antoñanzas, Carmelo Juárez-Castelló, et al. · SERIEs · 6
PDF
Channeling health economics research initiatives to improve decision-making processes in the EU
2013 · F. Antonanzas, R. Rodríguez-Ibeas · The European Journal of Health Economics · 5
PDF
Pharmaceutical patents, R&D incentives and access to new drugs: new ways of progress at the crossroad
2011 · Fernando Antoñanzas, Carmelo Juárez-Castelló, et al. · The European Journal of Health Economics · 5
PDF
Works count: 51
Citation count: 536
H-index: 12
I10-index: 16
Year
Topic
Type